CCC patients (n=94) | Referred patients with unplanned excision (n=71) | p-value | Statistical test | |
---|---|---|---|---|
Demographics | Students t test | |||
Male | 47.9% | 53.1% | 0.469 | |
Female | 52.1% | 46.9% | ||
Under 50 years of age | 27.7% | 33.3% | 0.396 | |
50 years of age and older | 72.3% | 66.7% | ||
Median age | 59.49 | 55.94 | 0.156 | |
Clinical data | ||||
FNCLCC grade | Chi2 test | |||
Low | 23.0% | 23.5% | 0.019 | |
Intermidiate | 21.8% | 40.0% | ||
High | 55.2% | 36.5% | ||
Tumour size | Chi2 test | |||
Size ≤ 5 cm (T1) | 30.2% | 51.8% | <0.001 | |
Size > 5 cm (T2) | 62.4% | 48.2% | ||
Tumour location with regard to fascia | Chi2 test | |||
Superficial (Ta) | 32.2% | 34.1% | 0.788 | |
Deep (Tb) | 67.8% | 65.9% | ||
NCCN stage | Chi2 test | |||
IA | 4.6% | 12.9% | <0.001 | |
IB | 24.1% | 15.3% | ||
IIA | 12.6% | 43.5% | ||
IIB | 14.9% | 9.4% | ||
III | 36.8% | 14.1% | ||
IV | 6.9% | 4.7% | ||
Histopathological diagnosis | Chi2 test | |||
Liposarcoma | 27.4% | 37.3% | 0.127 | |
Leiomyosarcoma | 4.8% | 4.8% | ||
Rhabdomyosarcoma | 2.4% | 3.6% | ||
Synovial sarcoma | 4.8% | 4.8% | ||
Malignant fibrous histiocytoma | 33.3% | 21.7% | ||
Fibrosarcoma | 8.3% | 13.3% | ||
Other | 19.0% | 14.5% |